MedTrace Logo

Neuropsychological Effects of Hydrocortisone in Patients With Partial Adrenal Insufficiency

NCT01089075 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2015-04-08

No results posted yet for this study

Summary

The purpose of this study is to evaluate the efficacy of hydrocortisone replacement therapy in patients with partial cortisol deficiency after traumatic brain injury or subarachnoid hemorrhage on cognitive function.

Conditions

  • Partial Corticotrope Insufficiency

Interventions

DRUG

Hydrocortisone

20 mg po for 7 days (2 tablets)

DRUG

Placebo

2 tablets po

Sponsors & Collaborators

  • Novo Nordisk A/S

    collaborator INDUSTRY

  • Max-Planck-Institute of Psychiatry

    lead OTHER

Principal Investigators

  • Günter K. Stalla, Prof. Dr. · Max-Planck-Institute, Munich

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-02-28
Primary Completion
2015-03-31
Completion
2015-03-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01089075 on ClinicalTrials.gov